Clinical Trial China phase 3
Based on the PSP´s significant findings in the investigated cancers of the Phase II trial, permission was granted by the Chinese Administration of Health Bureau to carry out a multi-center Phase III clinical trial. Fourteen hospitals including the eight who participated in the phase II trial conducted this randomized study from April 1996 to September 1997.
http://mushroomstudies.com/wp-content/uploads/2011/05/clin_trial_china-phase-III.pdf
